no statement of use filed
on 18 Jan 2021
Last Applicant/ Owned by
2 TOWER CENTER BOULEVARD, SUITE 1101C
EAST BRUNSWICK
NJ
08816
Serial Number
88712791 filed on 03rd Dec 2019
Registration Number
N/A
Correspondent Address
CASPER PHARMA LLC
CASPER PHARMA LLC
2 TOWER CENTER BOULEVARD, SUITE 1101C
2 TOWER CENTER BOULEVARD, SUITE 1101C
EAST BRUNSWICK, NJ 08816
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
"HC"
Pharmaceutical preparation of neomycin and polymyxin B sulfates and hydrocortisone otic suspension, for the treatment of superficial bacterial infections of the external auditory canal caused by organisms susceptible to the action of the antibiotics, and for the treatment of infections of mastoidectomy and fenestration cavities caused by organisms susceptible to the antibiotics "HC"
Pharmaceutical preparation of neomycin and polymyxin B sulfates and hydrocortisone otic suspension, for the treatment of superficial bacterial infections of the external auditory canal caused by organisms susceptible to the action of the antibiotics, and for the treatment of infections of mastoidectomy and fenestration cavities caused by organisms susceptible to the antibiotics
No 88712791
No Service/Collective Mark
No TMK-2019-03
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 19th Jan 2021 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 18th Jan 2021 | ABANDONMENT - NO USE STATEMENT FILED |
| 16th Jun 2020 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 21st Apr 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 21st Apr 2020 | PUBLISHED FOR OPPOSITION |
| 01st Apr 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 16th Mar 2020 | ASSIGNED TO LIE |
| 06th Mar 2020 | EXAMINER'S AMENDMENT ENTERED |
| 06th Mar 2020 | EXAMINERS AMENDMENT -WRITTEN |
| 06th Mar 2020 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
